Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Von Dem Borne, Peter A  [Clear All Filters]
Journal Article
Koster EAS, Borne PAVon Dem, van Balen P, van Egmond EHM, Marijt EWA, Veld SAJ, Jedema I, Snijders TJF, van Lammeren D, Veelken H, et al. Competitive repopulation and allo-immunological pressure determine chimerism kinetics after T-cell depleted allogeneic stem cell transplantation and donor lymphocyte infusions. Transplant Cell Ther. 2022.
Borne PAVon Dem, Kemps-Mols BM, de Wreede LC, van Beek AA, Snijders TJF, van Lammeren D, Tijmensen J, Sijs-Szabo A, Oudshoorn MA, Halkes CJM, et al. The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leuk Lymphoma. 2024:1-11.
Loeff FC, van Egmond EHM, Moes DJAR, Wijnands C, Borne PAVon Dem, Veelken H, Falkenburg JHFrederik, Jedema I, Halkes CJM. Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft. Transpl Immunol. 2019.
Koster EAS, Borne PAVon Dem, van Balen P, Marijt EWA, Tjon JML, Snijders TJF, van Lammeren D, Veelken H, Falkenburg JHFrederik, Halkes CJM, et al. Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation. Front Immunol. 2024;15:1335341.